Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing polychondritis.

Peter Gergely1, Gyula Poór

  • 1First Department of Rheumatology and Metabolic Osteology, National Institute of Rheumatology and Physiotherapy, H-1023 Frankel Leó 38-40, Budapest, Hungary.

Best Practice & Research. Clinical Rheumatology
|September 30, 2004
PubMed
Summary

Relapsing polychondritis (RP) is a rare autoimmune disease causing cartilage destruction. This review covers RP

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort study.

Arthritis research & therapy·2026
Same author

Articular cartilage thickness alterations in hind limb of young and aged PAC1 gene-deficient mice.

Cell and tissue research·2026
Same author

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.

Annals of the rheumatic diseases·2026
Same author

Redefining the Therapeutic Frontier in Autoimmune Disease.

International journal of rheumatic diseases·2025
Same author

Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study.

RMD open·2025
Same author

Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort.

Arthritis research & therapy·2025

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Relapsing polychondritis (RP) is a rare, multisystem autoimmune disorder.
  • It is characterized by inflammation and progressive destruction of cartilaginous tissues.
  • RP affects various cartilage sites, including ears, nose, joints, and airways, impacting life expectancy.

Purpose of the Study:

  • To review the main features of relapsing polychondritis.
  • To present seven clinical cases of RP.
  • To focus on recent findings in RP etiopathogenesis and novel treatment options.

Main Methods:

  • Literature review focusing on etiopathogenesis and treatment.
  • Clinical case series presentation.

Main Results:

  • RP presents with fluctuating but progressive disease course.
  • Challenges in RP management include its rarity, unknown cause, and varied presentation.
  • Recent advances in understanding RP's origins and new therapeutic strategies are discussed.

Conclusions:

  • RP is a complex autoimmune disease requiring comprehensive management.
  • Further research into etiopathogenesis is crucial for developing targeted therapies.
  • Novel treatment options offer potential for improved patient outcomes in RP.

Related Experiment Videos